#ESMO22 Highlights on nirogacestat in patients with progressing desmoid tumours: The DeFi study
1 Views
administrator
07/04/23
LBA2 - DeFi: A Phase 3, Randomized Controlled Trial of Nirogacestat Versus Placebo for Progressing Desmoid Tumors (DT)
Presented by Bernd Kasper, DE
Produced by the European Society for Medical Oncology
http://oncologypro.esmo.org
-
Category
Show more
Facebook Comments
No comments found